Frontiers | The Growing Role of Immunotherapy and Combination Strategies in Pancreatic and Hepatobiliary Cancers

The Growing Role of Immunotherapy and Combination Strategies in Pancreatic and Hepatobiliary Cancers

1,497
Total downloads
5,928
Total views and downloads

Articles

CASE REPORT

Published on 29 Jan 2025

Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients

Tara Seery
Lennie Sender
Omid Jafari
Frank Jones
Patricia Spilman
Sandeep B. Reddy
Patrick Soon-Shiong

doi 10.3389/fonc.2025.1472714

525 views

SYSTEMATIC REVIEW

Accepted on 28 Jan 2025

Enhanced Antitumor Activity of Combined Hepatic Arterial Infusion Chemotherapy with Lenvatinib and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma: A Meta-Analysis

Zhao Ling Ling
Xu Cheng
Deng Jie Wen
Ni Yang

doi 10.3389/fonc.2025.1513394

ORIGINAL RESEARCH

Accepted on 21 Jan 2025

Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma

Ziting Peng
Jianhui Dong
Shuyao Tang
Jiaxu Shi
Tongdong Shi

doi 10.3389/fonc.2025.1498887

CASE REPORT

Published on 17 Dec 2024

Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma

Hongying Liu
Yun Wang
Qian Zhang
Nengwen Ke

doi 10.3389/fonc.2024.1458517

425 views

ORIGINAL RESEARCH

Published on 11 Dec 2024

Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model

Joanna Napp
Paulina Siebel
Hans Rausch
Kenny Kuchta
Thomas Efferth
Frauke Alves
Volker Ellenrieder
Silke Cameron

doi 10.3389/fonc.2024.1454291

592 views

SYSTEMATIC REVIEW

Published on 11 Dec 2024

Prognostic role of systemic inflammation response index (SIRI) in patients with pancreatic cancer: a meta-analysis

Huifen Shen
Fei Zuo

doi 10.3389/fonc.2024.1465279

339 views

ORIGINAL RESEARCH

Published on 02 Dec 2024

Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular carcinoma and its predictive role and correlation with PD-L1 CTCs

Lin Xu
Xu Che

doi 10.3389/fonc.2024.1478596

396 views

CASE REPORT

Published on 24 Oct 2024

Case report: Combinations of immune checkpoint inhibitor, chemotherapy, and hyperthermia therapy avoid lymphatic recurrence in cholangiocarcinoma

Heng-Jui Chang
Chiao-Hsu Ke
Yu-Shan Wang

doi 10.3389/fonc.2024.1421340

566 views

SYSTEMATIC REVIEW

Published on 17 Oct 2024

Evaluating the benefits of adjuvant chemotherapy in patients with pancreatic cancer undergoing radical pancreatectomy after neoadjuvant therapy—a systematic review and meta-analysis

Jiahao Wu
Yike Zhang
Haodong Wang
Wenyi Guo
Chengqing Li
Yichen Yu
Han Liu
Feng Li

doi 10.3389/fonc.2024.1429386

610 views

CASE REPORT

Published on 15 Jul 2024

Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case

He-wei Zhang
Hai-bo Yu

doi 10.3389/fonc.2024.1428370

768 views
1 citation

Share on

Frontiers in Oncology

Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Impact

5,928Topic views
4,027Article views
1,497Article downloads

View impact

Submit your idea

Articles

Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients

Enhanced Antitumor Activity of Combined Hepatic Arterial Infusion Chemotherapy with Lenvatinib and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma: A Meta-Analysis

Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma

Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma

Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model

Prognostic role of systemic inflammation response index (SIRI) in patients with pancreatic cancer: a meta-analysis

Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular carcinoma and its predictive role and correlation with PD-L1 CTCs

Case report: Combinations of immune checkpoint inhibitor, chemotherapy, and hyperthermia therapy avoid lymphatic recurrence in cholangiocarcinoma

Evaluating the benefits of adjuvant chemotherapy in patients with pancreatic cancer undergoing radical pancreatectomy after neoadjuvant therapy—a systematic review and meta-analysis

Case report: Translational treatment of unresectable intrahepatic cholangiocarcinoma: Tislelizumab, Lenvatinib, and GEMOX in one case

Frontiers in Oncology

Impact